시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 혈관 색전술 시장 보고서(2025년)
Vascular Embolization Global Market Report 2025
상품코드 : 1824470
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈관 색전술 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.6%로 성장할 전망이며, 49억 달러로 성장이 예측됩니다. 예측 기간의 성장은 만성질환 환자 증가, 연구개발 활동에 대한 투자 증가, 저침습 처치에 대한 선호도 증가, 지리적 확대 및 헬스케어 접근, 가처분 소득의 상승 등에 기인합니다. 예측 기간 주요 동향으로는 기술 진보, 전략적 협업, 전략적 제휴, 혁신적인 혈관 색전술 장비 개발 등이 있습니다.

향후 5년간의 성장률 9.6%라고 하는 예측은 전회 예측으로부터 0.1%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 무역 마찰은 네덜란드와 아일랜드에서 개발된 색전 코일과 액체 색전제의 가격을 상승시켜 동맥류 치료 지연과 수술 비용 상승을 초래함으로써 미국의 인터벤셔널 라디올로지에 지장을 초래할 수 있습니다. 이 영향은 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 부정적인 영향으로 더욱 광범위하게 작용할 것으로 보입니다.

예상되는 혈관 질환의 유병률 증가는 혈관 색전술 시장의 성장을 가속합니다. 혈관 질환에는 동맥과 정맥과 같은 혈관에 영향을 미치는 다양한 장애가 포함되어 혈류 감소, 말초 혈관 질환, 복부 대동맥류, 심부정맥 혈전증, 아테롬성 동맥 경화증, 만성 정맥 부전, 말초 동맥 질환 등 다양한 상태로 이어집니다. 혈관 색전술은 이러한 질환의 치료제로서 혈관 폐색과 폐색을 동반한 출혈에 대처하고, 동맥류를 수리하며, 정맥으로 혈액 공급을 촉진합니다. 2023년 4월 HMP Communications LLC는 2020년 말초동맥질환(PAD)의 세계적 유병률은 2,100만 건으로, 2030년에는 2,380만 건에 이를 것으로 예측했습니다. 이것은 혈관 질환의 유병률 증가가 혈관 색전술 시장의 주요 촉진요인임을 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Vascular embolization is a minimally invasive procedure that utilizes different materials, including coils, particles, or liquid agents, to block or impede blood vessels, thereby halting arterial bleeding. This technique is employed for various purposes, such as treating malignancies, shrinking vascular abnormalities, or redirecting blood flow.

The main products associated with vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials injected or placed in specific regions to block or occlude blood vessels, effectively treating various medical conditions. These agents are utilized in different procedures to address medical issues such as tumors, aneurysms, and arteriovenous malformations (AVMs). Various embolization techniques include coiling devices and non-coiling devices, applied in diverse medical applications such as peripheral vascular diseases, oncology, urology, neurology, and others. These products cater to various end-users, including hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The vascular embolization market research report is one of a series of new reports from The Business Research Company that provides vascular embolization market statistics, including vascular embolization industry global market size, regional shares, competitors with a vascular embolization market share, detailed vascular embolization market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. This vascular embolization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular embolization market size has grown strongly in recent years. It will grow from $3.15 billion in 2024 to $3.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rising prevalence of vascular diseases, rise in demand for non-coiling devices, surge in the use of clot agents, increased awareness about advanced treatment options.

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growth in the cases of chronic diseases, rising investments in r&d activities, growing preference for minimally invasive procedures, geographic expansion and access to healthcare, rising disposable incomes. Major trends in the forecast period include technological advancements, strategic collaborations, strategic collaborations, development of innovative vascular embolization devices.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. interventional radiology by inflating prices of embolic coils and liquid embolics developed in the Netherlands and Ireland, resulting in delayed aneurysm treatments and higher procedural costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the prevalence of vascular diseases is set to drive the growth of the vascular embolization market. Vascular diseases encompass various disorders affecting blood vessels, including arteries and veins, leading to reduced blood flow and various conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases. Vascular embolization serves as a treatment for these disorders, involving the occlusion or obstruction of blood vessels to address bleeding, repair aneurysms, and enhance blood supply in veins. As of April 2023, HMP Communications LLC reported a global prevalence of 21 million cases of peripheral artery diseases (PAD) in 2020, projected to reach 23.8 million by 2030. This underlines how the increasing prevalence of vascular diseases is a key driver for the vascular embolization market.

The high prevalence of chronic kidney diseases is expected to drive the growth of the vascular embolization market in the future. Chronic Kidney Disease (CKD) is a condition characterized by the gradual and irreversible damage to the kidneys over time. Vascular embolization can be employed in CKD to control bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications arising from kidney biopsies or transplants, thereby avoiding the risks associated with open surgery, particularly for patients with compromised kidney function. For example, a report by ZS Associates, a UK-based Kidney Research Commission, indicated that the prevalence of kidney disease in the UK was estimated to affect 7.19 million people in 2023, over 10% of the population, and is projected to rise to 7.61 million by 2033, with the percentage of patients in later stages of the disease increasing from 45% to 51%. Thus, the rising prevalence of chronic kidney diseases is propelling the growth of the vascular embolization market.

A prominent trend in the vascular embolization market is the adoption of technological advancements by major companies. These innovations are geared towards sustaining their market positions and enhancing the effectiveness of vascular embolization procedures. For example, in June 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, introduced the Pipeline Vantage, a flex embolization device designed for the treatment of brain aneurysms. This device incorporates shield technology and features improved delivery design characteristics, making it more reliable for clinicians to transport, deploy, and treat brain aneurysms.

Major companies in the vascular embolization market are focusing on developing innovative products such as embolic systems to drive profitability. Embolic systems, comprising embolic agents and delivery devices, are utilized to intentionally block blood vessels in medical procedures. In October 2023, Sirtex Medical launched the Lava liquid embolic system (LES), offering a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small and hard-to-reach vessels, providing physicians with enhanced treatment options.

In August 2022, Boston Scientific Corporation acquired Obsidio. This acquisition aims to expand Boston Scientific Corporation's interventional oncology and embolization portfolio, offering unique options for physicians and patients dealing with hemorrhages, cancer, and other debilitating conditions. Obsidio specializes in minimally invasive blood vessel occlusion.

Major companies operating in the vascular embolization market include Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

North America was the largest region in the vascular embolization market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vascular embolization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Embolization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular embolization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for vascular embolization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular embolization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Vascular Embolization Market Characteristics

3. Vascular Embolization Market Trends And Strategies

4. Vascular Embolization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vascular Embolization Growth Analysis And Strategic Analysis Framework

6. Vascular Embolization Market Segmentation

7. Vascular Embolization Market Regional And Country Analysis

8. Asia-Pacific Vascular Embolization Market

9. China Vascular Embolization Market

10. India Vascular Embolization Market

11. Japan Vascular Embolization Market

12. Australia Vascular Embolization Market

13. Indonesia Vascular Embolization Market

14. South Korea Vascular Embolization Market

15. Western Europe Vascular Embolization Market

16. UK Vascular Embolization Market

17. Germany Vascular Embolization Market

18. France Vascular Embolization Market

19. Italy Vascular Embolization Market

20. Spain Vascular Embolization Market

21. Eastern Europe Vascular Embolization Market

22. Russia Vascular Embolization Market

23. North America Vascular Embolization Market

24. USA Vascular Embolization Market

25. Canada Vascular Embolization Market

26. South America Vascular Embolization Market

27. Brazil Vascular Embolization Market

28. Middle East Vascular Embolization Market

29. Africa Vascular Embolization Market

30. Vascular Embolization Market Competitive Landscape And Company Profiles

31. Vascular Embolization Market Other Major And Innovative Companies

32. Global Vascular Embolization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Embolization Market

34. Recent Developments In The Vascular Embolization Market

35. Vascular Embolization Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기